SCN5A and diabetes mellitus: The prevalences of hypertension or diabetes were not statistically significantly different between SCN5A-mut-positive patients (hypertension: 5/40, diabetes: 1/40) and SCN5A-mut-negative patients (hypertension: 14/98 [p = 0.8 vs. 5/40], diabetes: 5/98 [p = 0.5 vs. 1/40]).